RBC
CLX icon

Romano Brothers & Co’s Clorox CLX Stock Holding History

Romano Brothers & Co’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Sell
13,082
-95
-0.7% -$9.12K 0.13% 155
2026
Q1 		$1.37M Sell
13,177
-37
-0.3% -$4.2K 0.16% 142
2025
Q4 		$1.33M Sell
13,214
-922
-7% -$100K 0.15% 141
2025
Q3 		$1.74M Sell
14,136
-281
-2% -$34.9K 0.2% 121
2025
Q2 		$1.73M Buy
14,417
+3
+0% +$400 0.21% 117
2025
Q1 		$2.12M Buy
14,414
+131
+0.9% +$20K 0.27% 99
2024
Q4 		$2.32M Sell
14,283
-352
-2% -$57.6K 0.29% 93
2024
Q3 		$2.38M Sell
14,635
-61
-0.4% -$9.04K 0.3% 100
2024
Q2 		$2.01M Sell
14,696
-283
-2% -$39.3K 0.28% 107
2024
Q1 		$2.29M Sell
14,979
-137
-0.9% -$20.4K 0.31% 98
2023
Q4 		$2.16M Sell
15,116
-208
-1% -$27.7K 0.32% 93
2023
Q3 		$2.01M Sell
15,324
-42
-0.3% -$6.38K 0.31% 93
2023
Q2 		$2.44M Sell
15,366
-273
-2% -$44K 0.36% 90
2023
Q1 		$2.47M Buy
15,639
+32
+0.2% +$4.8K 0.38% 86
2022
Q4 		$2.19M Buy
15,607
+2
+0% +$284 0.33% 90
2022
Q3 		$2M Buy
+15,605
New +$2.25M 0.32% 96

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Romano Brothers & Co's CLX Position: Q2 2026 in Review

Romano Brothers & Co reduced its Clorox (CLX) stake by 0.72% in Q2 2026, selling an estimated $9.12K and leaving 13,082 shares worth $1.25M. The position accounts for 0.13% of the portfolio, ranked #155.

Romano Brothers & Co first reported a position in CLX in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.47M in Q1 2023. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Romano Brothers & Co held 13,082 shares of Clorox worth $1.25M as of Q2 2026.
  • Romano Brothers & Co sold 95 Clorox shares in Q2 2026, an estimated $9.12K.
  • Clorox made up 0.13% of Romano Brothers & Co's portfolio in Q2 2026, its #155 holding.
  • Romano Brothers & Co first reported a position in Clorox in Q3 2022 and has held it in 16 quarters since.
  • Romano Brothers & Co's Clorox position peaked at $2.47M in Q1 2023.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.